These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23356980)

  • 1. Targeting cell cycle regulation in cancer therapy.
    Diaz-Moralli S; Tarrado-Castellarnau M; Miranda A; Cascante M
    Pharmacol Ther; 2013 May; 138(2):255-71. PubMed ID: 23356980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors.
    Pitts TM; Davis SL; Eckhardt SG; Bradshaw-Pierce EL
    Pharmacol Ther; 2014 May; 142(2):258-69. PubMed ID: 24362082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
    Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
    J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cell cycle and apoptosis for the treatment of human malignancies.
    Senderowicz AM
    Curr Opin Cell Biol; 2004 Dec; 16(6):670-8. PubMed ID: 15530779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
    Montagnoli A; Moll J; Colotta F
    Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis.
    Matés JM; Segura JA; Alonso FJ; Márquez J
    Arch Toxicol; 2008 May; 82(5):273-99. PubMed ID: 18443763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins in cancer: targeting the 'chaperones'.
    Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z
    Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
    Perego P; Cossa G; Zuco V; Zunino F
    Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
    Kaubisch A; Schwartz GK
    Cancer J; 2000; 6(4):192-212. PubMed ID: 11038138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.
    Maddika S; Ande SR; Panigrahi S; Paranjothy T; Weglarczyk K; Zuse A; Eshraghi M; Manda KD; Wiechec E; Los M
    Drug Resist Updat; 2007; 10(1-2):13-29. PubMed ID: 17303468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
    Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
    Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor genes and ROS: complex networks of interactions.
    Vurusaner B; Poli G; Basaga H
    Free Radic Biol Med; 2012 Jan; 52(1):7-18. PubMed ID: 22019631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules as inhibitors of cyclin-dependent kinases.
    Huwe A; Mazitschek R; Giannis A
    Angew Chem Int Ed Engl; 2003 May; 42(19):2122-38. PubMed ID: 12761741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.